Dr. Aaron Farrokh takes a stand against oral cancer using OralID Fluorescence Technology
East Cedar Dental joined forces with Forward Science, the manufacturer of OralID, and became a provider of the ID For Life Program to promote early detection and public awareness of oral cancer in the office. Dr. Aaron Farrokh will be offering enhanced oral cancer screenings during scheduled appointments to new and current patients.
Oral Cancer is not a rare disease, and unfortunately it is on the rise. This year, approximately 53,000 will be diagnosed with oral cancer in the United States alone. Due to late stage discovery, one American dies every hour from oral cancer.
Dr. Aaron Farrokh uses an oral cancer screening device, OralID, in efforts to discover oral cancers in their earliest stages. Currently, 71% of oral cancers are found in late stages (stage III, IV), resulting in a 5-year survival rate of less than 50%. Finding these abnormalities in much earlier stages can increase the 5-year survival rate up to 80-90%. Those interested in receiving an oral cancer screening or learning more about our advanced technology implemented at East Cedar Dental, contact our office at (860) 667-0875 and ask about our OralID screenings, or visit our website at https://www.eastcedardental.com/
About Forward Science LLC
Forward Science is a biotech company based in Houston, TX. OralID, Forward Science’s flagship product, is an award winning oral cancer screening device that allows clinicians to Shine Light. Change Lives. by identifying abnormalities that may not be seen under traditional white light examinations. Forward Science quickly expanded its product portfolio in efforts to provide clinicians with a complete program to battle the rising trends of oral cancer. With the launch of the ID For Life Program, Forward Science has evolved into the industry leader for oral oncology. The ID For Life Program includes the following in an effort to change the trends for oral cancer: screening device (OralID), diagnostic tests (CytID, PathID, hpvID, phID), and treatment options (SalivaMAX).
Release ID: 88917642